ANI Pharmaceuticals | ANIP - Ebitda


ANI Pharmaceuticals reported $71.6M in EBITDA for its fiscal quarter ending in June of 2026.





Ebitda Change Date
AbbVie USD 3.69B 1.68B Mar/2026
ANI Pharmaceuticals USD 71.6M 6.69M Jun/2026
Aurora Cannabis CAD 3.7M 14.78M Mar/2026
Canopy Growth CAD -137M 134.13M Mar/2026
Eli Lilly USD 10.29B 1.86B Mar/2026
Heron Therapeutics USD -3.88M 5.63M Sep/2024
Hikma Pharmaceutical USD 369M 84M Dec/2024
Knight Therapeutics CAD 24.45M 3.46M Dec/2025
Nektar Therapeutics USD -38.9M 7.09M Mar/2026
Novartis USD 5.41B 431M Mar/2026
Omeros USD -47.96M 7.39M Sep/2023
Perrigo USD 141.6M 1.34B Mar/2026
Sun Pharmaceuticals INR 44.18B 4.63B Jun/2026
Teva Pharmaceutical Industries USD 474M 581M Jun/2026